Expression of aromatase CYP19 and its relationship with parameters in NSCLC

Frontiers in Bioscience

Volumn 14, Issue 6, 2009, Pages 2285-2292

  Oyama, Tsunehiro ^a   Kagawa, Norio ^b   Sugio, Kenji ^a   Uramoto, Hidetaka ^a   Hatano, Osamu ^c   Harada, Nobuhiro ^d   Kaneko, Kazuhiro ^e   Kawamoto, Toshihiro ^a   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b SAARLAND UNIVERSITY   (Germany)

^c NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Aromatase; Aromatase inhibitors; CYP; CYP19; Cytochrome P450; E. coli; ER; ERT; Estrogen receptor; Estrogen replacement therapy; Non small cell lung cancer; NSCLC; PGR; Progesterone receptor; Survival

Indexed keywords

ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS;

AROMATASE;

ARTICLE; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR SUPPRESSOR GENE;

AROMATASE; CARCINOMA, NON-SMALL-CELL LUNG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MUTATION;

EID: 63849206909     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3379     Document Type: Article

References (35)

1. Patrone, C., T. N. Cassel, K. Pettersson, Y. S. Piao, G. Cheng, P. Ciana, A. Maggi, M. Warner, J. A. Gustafsson & M. Nord: Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Mol Cell Biol, 23, 8542-52 (2003). (Pubitemid 37441291)
2. Martel, C., M. H. Melner, D. Gagne, J. Simard & F. Labrie: Widespread tissue distribution of steroid sulfatase, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD), 17 beta-HSD 5 alpha-reductase and aromatase activities in the rhesus monkey. Mol Cell Endocrinol, 104, 103-11 (1994).
3. Stabile, L. P., A. L. Davis, C. T. Gubish, T. M. Hopkins, J. D. Luketich, N. Christie, S. Finkelstein & J. M. Siegfried: Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res, 62, 2141-50 (2002). (Pubitemid 34408463)
4. Massaro, D. & G. D. Massaro: Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice. Am J Physiol Lung Cell Mol Physiol, 287, L1154-9 (2004). (Pubitemid 39507191)
5. Pietras, R. J., D. C. Marquez, H. W. Chen, E. Tsai, O. Weinberg & M. Fishbein: Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids, 70, 372-81 (2005). (Pubitemid 40616035)
6. Oyama, T., M. Morita, T. Isse, N. Kagawa, S. Nakata, T. So, M. Mizukami, Y. Ichiki, K. Ono, M. Sugaya, H. Uramoto, T. Yoshimatsu, T. Hanagiri, K. Sugio, T. Kawamoto & K. Yasumoto: Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer. Front Biosci, 10, 1156-61 (2005).
7. Coscio, A. M. & J. Garst: Lung cancer in women. Curr Oncol Rep, 8, 248-51 (2006). (Pubitemid 43970975)
8. Taioli, E. & E. L. Wynder: Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst, 86, 869-70 (1994).
9. Taioli, E., S. J. Garte, J. Trachman, S. Garbers, D. W. Sepkovic, M. P. Osborne, S. Mehl & H. L. Bradlow: Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst, 88, 617 (1996). (Pubitemid 26137585)
10. Oyama, T., K. Sugio, T. Isse, A. Matsumoto, N. Nose, H. Uramoto, T. Nozoe, M. Morita, N. Kagawa, T. Osaki, M. Muto, K. Yasumoto & T. Kawamoto: Expression of cytochrome P450 in non-small cell lung cancer. Front Biosci, 13, 5787-93 (2008).
11. Su, J. M., H. K. Hsu, H. Chang, S. L. Lin, H. C. Chang, M. S. Huang & H. H. Tseng: Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study. Anticancer Res, 16, 3803-6 (1996). (Pubitemid 27085052)
12. Kagawa, N., H. Hori, M. R. Waterman & S. Yoshioka: Characterization of stable human aromatase expressed in E. coli. Steroids, 69, 235-43 (2004). (Pubitemid 38748719)
13. Weinberg, O. K., D. C. Marquez-Garban, M. C. Fishbein, L. Goodglick, H. J. Garban, S. M. Dubinett & R. J. Pietras: Aromatase inhibitors in human lung cancer therapy. Cancer Res, 65, 11287-91 (2005). (Pubitemid 41821684)
14. Oyama, T., T. Osaki, T. Baba, Y. Nagata, M. Mizukami, T. So, S. Nakata, Y. Ichiki, H. Uramoto, M. Sugaya, T. Yoshimatsu, M. Morita, T. Hanagiri, K. Sugio, T. Kawamoto & K. Yasumoto: Molecular genetic tumor markers in non-small cell lung cancer. Anticancer Res, 25, 1193-6 (2005). (Pubitemid 40546789)
15. Kagawa, N., Q. Cao & K. Kusano: Expression of human aromatase (CYP19) in Escherichia coli by N-terminal replacement and induction of cold stress response. Steroids, 68, 205-9 (2003). (Pubitemid 36279172)
16. Nishihara, K., M. Kanemori, M. Kitagawa, H. Yanagi & T. Yura: Chaperone coexpression plasmids: differential and synergistic roles of DnaK-DnaJ-GrpE and GroEL-GroES in assisting folding of an allergen of Japanese cedar pollen, Cryj2, in Escherichia coli. Appl Environ Microbiol, 64, 1694-9 (1998). (Pubitemid 28234771)
17. Kagawa, N. & Q. Cao: Osmotic stress induced by carbohydrates enhances expression of foreign proteins in Escherichia coli. Arch Biochem Biophys, 393, 290-6 (2001). (Pubitemid 32907186)
18. Kusano, K., M. R. Waterman, M. Sakaguchi, T. Omura & N. Kagawa: Protein synthesis inhibitors and ethanol selectively enhance heterologous expression of P450s and related proteins in Escherichia coli. Arch Biochem Biophys, 367, 129-36 (1999). (Pubitemid 29394202)
19. Imai, T., H. Globerman, J. M. Gertner, N. Kagawa & M. R. Waterman: Expression and purification of functional human 17 alpha-hydroxylase/17, 20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17 alpha-hydroxylase/17, 20-lyase deficiency. J Biol Chem, 268, 19681-9 (1993). (Pubitemid 23270759)
20. Mountain, C. F. & C. M. Dresler: Regional lymph node classification for lung cancer staging. Chest, 111, 1718-23 (1997). (Pubitemid 27260108)
21. Brambilla, E., W. D. Travis, T. V. Colby, B. Corrin & Y. Shimosato: The new World Health Organization classification of lung tumours. Eur Respir J, 18, 1059-68 (2001). (Pubitemid 34092881)
22. Oyama, T., K. Sugio, H. Uramoto, T. Kawamoto, N. Kagawa, S. Nadaf, D. Carbone & K. Yasumoto: Cytochrome P450 expression (CYP) in non-small cell lung cancer. Front Biosci, 12, 2299-308 (2007).
23. Oyama, T., N. Kagawa, N. Kunugita, K. Kitagawa, M. Ogawa, T. Yamaguchi, R. Suzuki, T. Kinaga, Y. Yashima, S. Ozaki, T. Isse, Y. D. Kim, H. Kim & T. Kawamoto: Expression of cytochrome P450 in tumor tissues and its association with cancer development. Front Biosci, 9, 1967-76 (2004). (Pubitemid 38918646)
24. Oyama, T., T. Kawamoto, T. Mizoue, K. Yasumoto, Y. Kodama & T. Mitsudomi: N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation. Anticancer Res, 17, 577-81 (1997). (Pubitemid 27105531)
25. Lau, S. M., P. A. Harder & D. P. O'Keefe: Low carbon monoxide affinity allene oxide synthase is the predominant cytochrome P450 in many plant tissues. Biochemistry, 32, 1945-50 (1993). (Pubitemid 23086044)
26. Wang, L. H., A. L. Tsai & P. Y. Hsu: Substrate binding is the rate-limiting step in thromboxane synthase catalysis. J Biol Chem, 276, 14737-43 (2001).
27. Meigs, R. A. & K. J. Ryan: Enzymatic aromatization of steroids. I. Effects of oxygen and carbon monoxide on the intermediate steps of estrogen biosynthesis. J Biol Chem, 246, 83-7 (1971).
28. Tosha, T., N. Kagawa, T. Ohta, S. Yoshioka, M. R. Waterman & T. Kitagawa: Raman Evidence for Specific Substrate-Induced Structural Changes in the Heme Pocket of Human Cytochrome P450 Aromatase during the Three Consecutive Oxygen Activation Steps. Biochemistry, 45, 5631-40 (2006). (Pubitemid 43673193)
29. Liehr, J. G., W. F. Fang, D. A. Sirbasku & A. Ari-Ulubelen: Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem, 24, 353-6 (1986).
30. Li, J. J. & S. A. Li: Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc, 46, 1858-63 (1987). (Pubitemid 17075932)
31. Spivack, S. D., G. J. Hurteau, A. A. Reilly, K. M. Aldous, X. Ding & L. S. Kaminsky: CYP1B1 expression in human lung. Drug Metab Dispos, 29, 916-22 (2001). (Pubitemid 32488651)
32. Lee, A. J., M. X. Cai, P. E. Thomas, A. H. Conney & B. T. Zhu: Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology, 144, 3382-98 (2003). (Pubitemid 36904414)
33. Mah, V., D. B. Seligson, A. Li, D. C. Marquez, Wistuba, II, Y. Elshimali, M. C. Fishbein, D. Chia, R. J. Pietras & L. Goodglick: Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res, 67, 10484-90 (2007). (Pubitemid 350070824)
34. Osborne, C. K.: Tamoxifen in the treatment of breast cancer. N Engl J Med, 339, 1609-18 (1998). (Pubitemid 28536137)
35. Fisher, B., J. P. Costantino, D. L. Wickerham, R. S. Cecchini, W. M. Cronin, A. Robidoux, T. B. Bevers, M. T. Kavanah, J. N. Atkins, R. G. Margolese, C. D. Runowicz, J. M. James, L. G. Ford & N. Wolmark: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst, 97, 1652-62 (2005). (Pubitemid 41672231)